Spun out of research at the University of Iowa, NanoMedTrix LLC develops nanoparticles for regenerative medicine applications. In cancer, NanoMedtrix material has been designed to target solid tumors such as: bladder, colorectal and neural tumors. The same nano-compounds are adjustable to provide valuable information on the disease process of multitude illnesses. The company's products combine fluorescence, magnetic resonance imaging (MRI) or computer tomography (CT) with Ultrasound Imaging (UI) signaling capability. Its customizable compounds can be engineered to tag tumors or cells of interest.
